Novogene Global Risk Report
Explore Novogene Global across six non‑financial risk dimensions:ESG, Workforce, News & Media, Cybersecurity, Legal & Regulatory, Operational. Unlock the full report, original sources and timelines, and enable continuous monitoring.
Summary
🏗️ Operational & Business Continuity
Novogene's recent activities illustrate its strategic expansion and focus on maintaining robust sequencing capabilities. The company has demonstrated foresight in strengthening its operational foundations across key global markets, which is vital for its continued success in the biotechnology research industry. However, these expansions also suggest potential operational risks if the demand does not meet expectations.
- Novogene Europe expanded its sequencing capabilities with the addition of a fifth NovaSeq X Plus system in 🗓 July 3, 2025.
- The establishment of a new subsidiary in Korea was announced to accelerate multi-omics research on 🗓 June 23, 2025.
- Novogene America launched a new single-cell lab in San Jose, CA, based on chromium platform powered by 10x Genomics on 🗓 August 1, 2022.
📜 Innovation & R&D
Innovation remains at the heart of Novogene's strategy. The company continues to push the boundaries of genomic research, reflecting its commitment to staying at the forefront of technological advancements. This commitment to innovation provides significant opportunities but also requires sustained investment in research and expertise.
- On 🗓 June 5, 2025, Novogene expanded its proteomics portfolio by being certified for Olink® services across multiple labs.
- Novogene agreed to buy ten PacBio Sequel Systems for DNA sequencing services on 🗓 January 16, 2017.
- Novogene unveiled an intelligent next generation sequencing delivery platform called Falcon on 🗓 March 24, 2020.
📜 Innovation & R&D
Innovation remains central to Novogene's mission, evidenced by their strategic acquisitions and partnerships. Maintaining a cutting-edge approach in such a competitive field underlines their dedication to advancing genomic research. This continuous investment in R&D showcases the company's pursuit of excellence and leadership in biotechnology.
- On 🗓 June 26, 2024, Novogene conducted a high-resolution 16s rRNA gene next generation sequencing study related to Alzheimer's and Parkinson's disease.
- Comparative transcriptomic immune responses study involving mullet (Mugil cephalus) was published on 🗓 June 26, 2024.
- Novogene America launched the Falcon II, a superpowered robot scientist for autonomously intelligent NGS delivery, on 🗓 September 7, 2022.
Profile
News & Media
Real‑time aggregation of trusted sources tracking company‑related events with sentiment and topic tags for rapid risk triage.
Sign up to unlock Novogene Global’s complete news feed with sentiment and topic tags.
View Full ReportEntity List
Continuous third‑party screening across global sanctions, enforcement, and watchlist sources with unified entity resolution and real‑time alerts.
| Name | Issuer | Status |
|---|---|---|
| ACF List of War Enablers | Anti-Corruption Foundation | |
| African Development Bank Debarred Entities | African Development Bank Group | |
| Argentina Members of Parliament | Honorable Cámara de Diputados de la Nación Argentina | |
| Argentina RePET Sanctions | Ministerio de Justicia | |
| Armenia Public Officials and Associates | Hetq Online | |
| Asian Development Bank Sanctions | Asian Development Bank | |
| Australian Sanctions Consolidated List | Department of Foreign Affairs and Trade | |
| Democratic People's Republic Of Korea (North Korea) Sanctions Regime | Department of Foreign Affairs and Trade | |
| Former Federal Republic Of Yugoslavia Sanctions Regime | Department of Foreign Affairs and Trade | |
| Iran Sanctions Regime | Department of Foreign Affairs and Trade |
Sign up to unlock Novogene Global’s sanctions, enforcement, and watchlist risk profile.
View Full ReportESG
Verification of declared ESG commitments and certifications with evidence links, score signals, and status updates across E, S, and G.
| Name | Status |
|---|---|
| Sustainable Finance Disclosure Regulation | |
| Global Reporting Initiative Standards | |
| EU Taxonomy Regulation | |
| EU Corporate Sustainability Reporting Directive | |
| California Transparency in Supply Chains Act | |
| EU Non-Financial Reporting Directive | |
| ISO 14001 | |
| Sustainability Accounting Standards Board Standards | |
| Task Force on Climate-related Financial Disclosures | |
| UN Guiding Principles on Business and Human Rights |
Sign up to unlock Novogene Global’s ESG commitments, certifications, and controversy signals.
View Full ReportCybersecurity
Verification of adherence to recognized security standards, mapping control coverage and gaps affecting third‑party and supply‑chain risk.
| Certification | Status |
|---|---|
| General Data Protection Regulation | |
| Digital Operational Resilience Act | |
| Cybersecurity Maturity Model Certification | |
| NIST Cybersecurity Framework | |
| NIST 800-53 Revision 5 | |
| California Consumer Privacy Act | |
| ISO/IEC 27001 | |
| Health Insurance Portability and Accountability Act | |
| Payment Card Industry Data Security Standard | |
| Federal Information Security Modernization Act |
Sign up to unlock Novogene Global’s security standards, control gaps, and exposure risks.
View Full ReportGet Novogene Global's full Non-Financial Risk Report
By signing up, you agree to our Terms and Privacy Policy.